Inflammation Program Immune Modulation Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflammation Program Immune Modulation Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflammation Program Immune Modulation Section Today - Breaking & Trending Today

OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development

Published: December 9, 2021

/PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera...

Source: prnewswire.com

Related Topics:

United StatesUnited KingdomKendall SquareChristopher BahlMichael KreppsKukje PharmaDennis KlinmanNational Cancer InstituteInflammation Program Immune Modulation SectionSx CompanyDartmouth UniversityUniversity Of PennsylvaniaOncopep IncUniversity Of MaineInstitute For Protein InnovationTera ScienceMassachusetts Based OncopepBoston KendallScientific AdvisorySenior InvestigatorInflammation ProgramImmune ModulationProtein DesignProtein Innovation

OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development

Published: December 9, 2021

/PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera...

Source: prnewswire.com

Related Topics:

United StatesUnited KingdomKendall SquareChristopher BahlMichael KreppsKukje PharmaDennis KlinmanNational Cancer InstituteInflammation Program Immune Modulation SectionSx CompanyDartmouth UniversityUniversity Of PennsylvaniaOncopep IncUniversity Of MaineInstitute For Protein InnovationTera ScienceMassachusetts Based OncopepBoston KendallScientific AdvisorySenior InvestigatorInflammation ProgramImmune ModulationProtein DesignProtein Innovation